Dr. Mohamad Azzam Ziade

Consultant, Oncology-Hematology

Speciality: Oncology

Practice Locations: Al Zahra Hospital, Sharjah


Dr. Ziade obtained a National Diploma in Medical Oncology from the University of Padova (1999). He followed the school of clinical hematology and completed his master degree in bone marrow transplant (2003). Then he started the program of M.R.C Path at Kings College hospital, in the Clinical Hematology department, London (2008 - 2012).



Dr. Ziade works at the University Hospital of Rafeik Hariri Beirut, Lebanon since 2012 as head of department of Bone marrow transplant and Oncology-Hematology department.



Dr. Ziade’s expertise is in Thalassemia and Sickle cell anaemia Bone Marrow Transplantation with extensive knowledge relative to haematological diseases (Benign and Malignant), haemoglobinopathy, haemostatic disorders, haemophilia and solid tumours.



Dr. Ziade is author of different articles including “Neoadjuvant moderately high-dose chemotherapy with rh-G-CSF in locally advanced breast cancer (Tumori 2001 Jul-Aug; 87 (4):223-8)”. He also collaborated in more than 10 congressional abstracts including “Full dose (FD) Chemotherapy (CT) plus Lenogastrim and Low Dose (LD) CT in Elderly patients with small cell lung cancer. A Phase II randomised FONICAP-GSTV study”.



Dr. Azzam speaks English, Italian, French and Arabic.



His area of expertise are:




  •     Thalassemia and Sickle cell anaemia Bone Marrow Transplantation


  •     Haematological diseases (Benign and Malignant),


  •     Haemoglobinopathy, haemostatic disorders, haemophilia and solid tumours.


Practice Locations

Al Zahra Hospital, Sharjah
Al Zahra Hospital, Sharjah

Al Zahra St., Near Clock Tower, Al Musalla, P.O. Box: 3499, Sharjah, United Arab Emirates.

Thank you for visiting our website!
Can you give us a minute to share your browsing experience?

NMC uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy